798 related articles for article (PubMed ID: 28949410)
1. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Truong J; Veillette JJ; Forland SC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133561
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
Dilworth TJ; Casapao AM; Ibrahim OM; Jacobs DM; Bowers DR; Beyda ND; Mercier RC
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617094
[TBL] [Abstract][Full Text] [Related]
4. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
6. β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.
Dilworth TJ; Ibrahim O; Hall P; Sliwinski J; Walraven C; Mercier RC
Antimicrob Agents Chemother; 2014; 58(1):102-9. PubMed ID: 24145519
[TBL] [Abstract][Full Text] [Related]
7. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
[TBL] [Abstract][Full Text] [Related]
8. Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.
Davis JS; Sud A; O'Sullivan MVN; Robinson JO; Ferguson PE; Foo H; van Hal SJ; Ralph AP; Howden BP; Binks PM; Kirby A; Tong SYC; ; ; Tong S; Davis J; Binks P; Majumdar S; Ralph A; Baird R; Gordon C; Jeremiah C; Leung G; Brischetto A; Crowe A; Dakh F; Whykes K; Kirkwood M; Sud A; Menon M; Somerville L; Subedi S; Owen S; O'Sullivan M; Liu E; Zhou F; Robinson O; Coombs G; Ferguson P; Ralph A; Liu E; Pollet S; Van Hal S; Foo H; Van Hal S; Davis R
Clin Infect Dis; 2016 Jan; 62(2):173-180. PubMed ID: 26349552
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
10. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
McConeghy KW; Bleasdale SC; Rodvold KA
Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
Wong D; Wong T; Romney M; Leung V
BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
[TBL] [Abstract][Full Text] [Related]
13. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Jorgensen SCJ; Zasowski EJ; Trinh TD; Lagnf AM; Bhatia S; Sabagha N; Abdul-Mutakabbir JC; Alosaimy S; Mynatt RP; Davis SL; Rybak MJ
Clin Infect Dis; 2020 Jun; 71(1):1-10. PubMed ID: 31404468
[TBL] [Abstract][Full Text] [Related]
15. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
[TBL] [Abstract][Full Text] [Related]
16. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
[TBL] [Abstract][Full Text] [Related]
17. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
Kullar R; Davis SL; Levine DP; Rybak MJ
Clin Infect Dis; 2011 Apr; 52(8):975-81. PubMed ID: 21460309
[TBL] [Abstract][Full Text] [Related]
18. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
Trials; 2016 Mar; 17():170. PubMed ID: 27029920
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
Wong D; Wong T; Romney M; Leung V
Ann Clin Microbiol Antimicrob; 2016 Apr; 15():27. PubMed ID: 27112143
[TBL] [Abstract][Full Text] [Related]
20. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
